Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells.
about
Hepatic farnesoid X-receptor isoforms α2 and α4 differentially modulate bile salt and lipoprotein metabolism in miceCellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking ExperimentsImmunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells.Glial grafting for demyelinating disease.Marker tolerant, immunocompetent animals as a new tool for regenerative medicine and long-term cell tracking.Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice.White paper on how to go forward with cell-based advanced therapies in Europe.Evaluation of Tat-encoding bicistronic human immunodeficiency virus type 1 gene transfer vectors in primary canine bone marrow mononuclear cells.Animal models for medical countermeasures to radiation exposure.Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation.Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR.Modeling promising nonmyeloablative conditioning regimens in nonhuman primates.Gene therapy for platelet disorders: studies with Glanzmann's thrombasthenia.Foamy-virus-mediated gene transfer to canine repopulating cells.Critical variables in the conversion of marrow cells to skeletal muscle.Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys.Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaques.Hematopoietic stem cell gene therapy with drug resistance genes: an update.A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy.Mesenchymal stem cell delivery into rat infarcted myocardium using a porous polysaccharide-based scaffold: a quantitative comparison with endocardial injection.Reconstitution of the myeloid and lymphoid compartments after the transplantation of autologous and genetically modified CD34+ bone marrow cells, following gamma irradiation in cynomolgus macaques.Engineering stem cells for therapy.Noninvasive imaging of cell-mediated therapy for treatment of cancer.Cartilage repair: past and future--lessons for regenerative medicine.Cost-effective sequence-based nonhuman primate MHC class I genotyping from RNAA transgenic-cloned pig model expressing non-fluorescent modified Plum.In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectorsSuicide gene therapy for graft-versus-host disease.Recognition of cellular implants by the brain's innate immune system.Reporter gene imaging of immune responses to cancer: progress and challenges.Development of a cyclosporin-A-induced immune tolerant rat model to test marrow allograft cell type effects on bone repair.Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo.Calmodulin kinase II inhibition disrupts cardiomyopathic effects of enhanced green fluorescent protein.Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance.Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.Therapeutic effect of dendritic cells loaded with a fusion mRNA encoding tyrosinase-related protein 2 and enhanced green fluorescence protein on B16 melanoma.Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene.A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.
P2860
Q27320737-FD67A5D1-0D21-4311-8945-D7CCC28BD0DDQ28075323-57305263-7333-4F91-9E7F-F3EF31D169CCQ30413268-AC3108FC-FCA6-4BBA-8E7C-426941E8A490Q30500898-B368AFEA-D7A7-4F30-921A-50F418FBFFB4Q33287223-DD57B80A-01E4-4C05-B547-E09E1FE306F8Q33496681-C567E8C4-0B72-4DD4-B63F-6D08A1DCCF2CQ34331082-ADBED908-A2B1-47B3-ADB7-A1BF7D7F098CQ34342523-321BA048-D47D-4057-BDDA-75F6A9E553EEQ34491137-1644A757-7F99-48D9-BC2C-23EFDEE8215DQ34504487-B88F7B72-9EF9-41BD-892E-A5E09766F8A2Q34657661-528D2216-2F1E-4D9C-9C38-0EF5273F354EQ34729799-7BDEE9F8-83EC-4C26-A0F8-BBBB7304D6CEQ35589483-2A232151-B6E7-49B6-B6E0-A6B39CBAA0C5Q35615750-1A3CFCF3-0C98-4412-BEE1-0D6E728AF19AQ35848052-BE38BE6E-65C0-484B-BFDD-724C705DDF61Q35849500-C51333BC-4397-48E0-9E5C-8FB673D5B129Q35939500-8D4E7BBF-ABB5-4384-9180-20FDCBE2F099Q36114246-41A9EBAD-0AA1-4FFA-AD95-4653B4B65322Q36204222-8124E1F5-E504-4A71-BD87-AC4768DA0021Q36613715-0530D5CA-1EAF-4322-8179-0468340DD521Q36765397-43F91D5C-ADAB-4345-BA6D-1BA6BE0E1887Q36766589-310845FE-3AA8-429B-8447-58560D921430Q36804669-DA5CC950-BDFF-4DAF-B0C7-7332FA510200Q37181560-40400D22-9FA9-4FAE-BC92-1FB8908AD38AQ37296148-CE3DBDF7-612C-4FEB-901D-40A241B20720Q37320885-2A6390FF-22B7-4E35-9224-DF847F1E31FEQ37369738-CD4CE579-426A-4CAA-A644-6E395864462EQ37394036-ED403FF3-A434-45A8-8EEB-00235A6BF12BQ37773293-A025FFCF-A7B7-4571-8550-8D6CD67B4B25Q37811884-20792648-C70D-4C08-A0F7-66EACF6E6AF7Q38003152-BEC8DEAE-8CFE-4CF1-A200-CB5DEEF8D9DCQ39037470-899EDDB3-FAF2-41FA-B02F-BD808320FA9AQ40221155-E61DD03C-9865-4958-925F-0A801C6A2E97Q41504062-70D9E6F8-B584-4065-8B04-1C63EF6A5B00Q42069114-02494BB7-77AD-46FD-8CFC-E7DE0DC99580Q43951035-D2C0BE70-FB61-4BCE-B28C-D8D31CE35DCAQ44078792-2C138726-7A9C-4750-92DD-EB2C353125B6Q45208296-4EADBEB9-BC5B-4A0C-8C33-F174F79D5935Q45855490-D85217FD-6024-4804-8BAC-290129EEE650Q45859123-F90BC31C-E02B-4CF0-BABE-6F176D3B43E9
P2860
Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Induction of cytotoxic T lymph ...... splantation of transduced CD34
@nl
Induction of cytotoxic T lymph ...... d CD34(+) hematopoietic cells.
@en
type
label
Induction of cytotoxic T lymph ...... splantation of transduced CD34
@nl
Induction of cytotoxic T lymph ...... d CD34(+) hematopoietic cells.
@en
prefLabel
Induction of cytotoxic T lymph ...... splantation of transduced CD34
@nl
Induction of cytotoxic T lymph ...... d CD34(+) hematopoietic cells.
@en
P2093
P356
P1433
P1476
Induction of cytotoxic T lymph ...... d CD34(+) hematopoietic cells.
@en
P2093
Glickman R
Johnson RP
Rosenzweig M
P304
P356
10.1182/BLOOD.V97.7.1951
P407
P577
2001-04-01T00:00:00Z